Member of the board of directors of E3Bio, Glionova, Inthera, ObsEva and Orphazyme Spent four years with Novo Seeds, building a strong portfolio of seed and Series A stage companies, before joining Novo Ventures in 2016 Previously: Apposite Capital PhD in Neuroscience from University College London, an MBA with distinction from University of Cambridge, and a 1st class BA from University of Oxford
Management